Redefining Return on Investment in Innovation

A highlight from Ep 039 with Dr. Nassir Mokarram

I talk with Dr. Nassir Mokarram about why it’s time for universities to rethink how they reward their researchers.

Publishing papers matters, but so does getting discoveries out of the lab and into the hands of patients. We discuss what it would look like to create tenure tracks that value translation, collaboration, and real-world outcomes as much as academic prestige.

Full Episode: https://youtu.be/ex1hDKRPrxg?si=E-ncg6qGAAWM194x

Keywords: biomedical innovation, brain cancer research, GBM device, translational medicine, entrepreneurship in academia, Emory University, Georgia Tech innovation, AI in healthcare, leadership podcast, university commercialization, intellectual property, venture capital in biotech, startup ecosystem Atlanta, academic entrepreneurship, medical device innovation, Badass Leaders Podcast, Angela Gill Nelms, Nasir Mokarram, higher education future, leadership vs management, biotech funding strategy

Questions Answered: How can universities reward innovation and entrepreneurship? How can AI lower the cost of drug and device development? Why is IP protection essential for healthcare startups? How can academia and industry work together more effectively? What can Atlanta learn from Silicon Valley’s startup evolution? How do we train the next generation of entrepreneurial scientists? What does the future of higher education look like in the AI era?